In our previous articles, we reported that the Federal Circuit affirmed the district court’s decision on December 20, 2024 ...

NEW YORK CITY, NY / ACCESS Newswire / March 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

The US shift toward steep tariffs will likely make drugs more expensive and limit access for patients, according to one of ...

Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the ...

Corcept's new drug, relacorilant, shows promise with positive Phase 3 results and an FDA decision expected. Learn more about ...

Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version ...

Generic drugmakers could be significantly impacted by President Trump's decision to double the tariff on Chinese goods to 20% ...

The shoe brand has launched "For Playground Earth," a new anthem and collection created to "push people to play outside." ...

Federal Circuit says only patents claiming the active ingredient of a drug are eligible for listing | Injunction against Teva ...

Weeks after settling a five-year patent dispute with the U.S. | Gilead set aside approximately $200 million for a potential ...

Teva Pharmaceutical Industries Ltd. failed to convince the Federal Circuit to reconsider a December ruling that five patents ...

This season’s collection, and future collections to come, are designed to help connect people to playground earth by equipping generations of adventurers with the footwear they need to double backflip ...